Queensland biotech venture Microbio hunts for cash as bloodstream infection test trials prove positive
Biotech scale-up Microbio is looking to raise capital following positive domestic pilot study results for its bloodstream infection (BSI) test ahead of taking it to market The Brisbane-based venture’s InfectID-BSI test has the potential for significant improvement in detecting bloodstream infection and sepsis, the world’s mostly deadly infection, with 11 million deaths annually. InfectID-BSI is an in… Read more »